Nebulization of NanoCrystals™: Production of a Respirable Solid-in-Liquid-in-Air Colloidal Dispersion

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Pharmaceutical Research

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1023/A:1012024021511PMID 9034231
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nebulization of Fluids of Different Physicochemical Properties with Air-Jet and Ultrasonic Nebulizers

  1995cited by this paper
• Operating characteristics of 18 different continuous-flow jet nebulizers with beclomethasone dipropionate liposome aerosol.

  1994cited by this paper
• Behavior of Nebulizing Solutions and Suspensions

  1994cited by this paper
• Some functional aspects of air-jet nebulizers

  1994cited by this paper
• Evaporation of Aqueous Aerosols Produced by Jet Nebulizers: Effects on Particle Size and Concentration of Solution in the Droplets

  1994cited by this paper
• Efficacy and safety of inhaled corticosteroids in asthma. Report of a workshop held in Eze, France, October 1992.

  1993cited by this paper
• Deposition Patterns of Aerosolized Drugs Within Human Lungs: Effects of Ventilatory Parameters

  1993cited by this paper
• Variability in the measurement of nebulized aerosol deposition in man.

  1991cited by this paper
• Respiratory Drug Delivery

  1989cited by this paper
• Development of a systematic theory of suspension inhalation aerosols. II. Aggregates of monodisperse particles nebulized in polydisperse droplets

  1988cited by this paper
• Deposition, retention, and clearance of inhaled particles.

  1980cited by this paper
• Deposition and retention models for internal dosimetry of the human respiratory tract. Task group on lung dynamics.

  1966cited by this paper

• Inhalable Nanotechnology-Based Drug Delivery Systems for the Treatment of Inflammatory Lung Diseases

  2025cites this paper
• Nano-Formulations for Pulmonary Delivery: Past, Present, and Future Perspectives

  2024cites this paper
• A short history of drug nanocrystals – methods, milestones and meaning in pharmaceutical technology

  2024cites this paper
• Inhaled Nanoparticulate Systems: Composition, Manufacture and Aerosol Delivery

  2024cites this paper
• Lessons from the history of inorganic nanoparticles for inhalable diagnostics and therapeutics.

  2023cites this paper
• Airway mucus in pulmonary diseases: Muco-adhesive and muco-penetrating particles to overcome the airway mucus barriers.

  2023cites this paper
• Nano-delivery to the lung - by inhalation or other routes and why nano when micro is largely sufficient?

  2022cites this paper
• Transformation of Meloxicam Containing Nanosuspension into Surfactant-Free Solid Compositions to Increase the Product Stability and Drug Bioavailability for Rapid Analgesia

  2019cites this paper
• Drug nanocrystals: Fabrication methods and promising therapeutic applications.

  2019cites this paper
• DDDT_A_220876 4007..4020

  2019cites this paper
• Size effect of curcumin nanocrystals on dissolution, airway mucosa penetration, lung tissue distribution and absorption by pulmonary delivery.

  2019cites this paper
• REVIEW ON NANOSUSPENSION: AN EMERGING TECHNOLOGY

  2018cites this paper
• Therapeutics Applications of Nanosuspension in Topical/ Mucosal Drug Delivery

  2018cites this paper
• Recent advances in the engineering of nanosized active pharmaceutical ingredients: Promises and challenges.

  2016cites this paper
• Nanosuspension: Principles, Perspectives and Practices.

  2016cites this paper
• Methods of Nanonization of Drugs for Enhancing their Dissolution

  2016cites this paper
• Generation and Evaporation of Microsprays

  2016cites this paper
• Drug nanosuspensions: a ZIP tool between traditional and innovative pharmaceutical formulations

  2015cites this paper
• Aerosol Performance and Stability of Liposomes Containing Ciprofloxacin Nanocrystals

  2015cites this paper
• Pulmonary delivery of anti-inflammatory agents

  2015influential citation
• Heat induced evaporative antisolvent nanoprecipitation (HIEAN) of itraconazole.

  2014cites this paper
• Emerging Nanotechnology Approaches for Pulmonary Delivery of Vaccines

  2014cites this paper
• Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: a review of the state of the art.

  2014cites this paper
• NANOCRYSTAL TECHNOLOGY AND DRUG DELIVERY

  2014cites this paper
• Formulation Development and Optimization of Nitrendipine Nanosuspension with Improved Pharmacokinetic Characteristics

  2013cites this paper
• Liquid antisolvent precipitation and stabilization of nanoparticles of poorly water soluble drugs in aqueous suspensions: Recent developments and future perspective

  2012cites this paper
• Chapter 5.2:Nanostructures for Overcoming the Pulmonary Barrier: Drug Delivery Strategies

  2012cites this paper
• Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology.

  2011cites this paper
• Alternatives to conventional suspensions for pulmonary drug delivery by nebulisers: a review.

  2011cites this paper
• Nanoparticles for Pulmonary Delivery

  2011cites this paper
• Physical and chemical stability of drug nanoparticles.

  2011cites this paper
• Formation, characterization, and fate of inhaled drug nanoparticles.

  2011influential citation
• Comparison of bioavailability of amorphous versus crystalline itraconazole nanoparticles via pulmonary administration in rats.

  2010cites this paper
• Pulmonary delivery of isoxyl particles to treat Mycobacterium tuberculosis

  2010cites this paper
• Improvement in the bioavailability of poorly water-soluble drugs via pulmonary delivery of nanoparticles

  2009cites this paper
• In vivo assessment of oral administration of probucol nanoparticles in rats.

  2008cites this paper
• Formation mechanism of colloidal nanoparticles obtained from probucol/PVP/SDS ternary ground mixture.

  2008cites this paper
• Morphology and surface States of colloidal probucol nanoparticles evaluated by atomic force microscopy.

  2008cites this paper
• Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products.

  2008cites this paper
• Investigations on Factors Affecting Chitosan for Dissolution Enhancement of Oxcarbazepine by Spray Dried Microcrystal Formulation With an Experimental Design Approach

  2007cites this paper
• Drug Nanocrystals—The Universal Formulation Approach for Poorly Soluble Drugs

  2007cites this paper
• The nanoscale in pulmonary delivery. Part 2: formulation platforms

  2007cites this paper
• Particle Size Analysis in Pharmaceutics: Principles, Methods and Applications

  2007cites this paper
• Particle Engineering for Pulmonary Drug Delivery

  2007cites this paper
• Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system.

  2007cites this paper
• Nanoparticle formation of poorly water-soluble drug by co-grinding with polymer and solubilizing agent

  2006cites this paper
• Novel Surfactant Therapy for Developing Countries: Current Status and Future Directions

  2005cites this paper
• Supercritical fluid technology for enhanced drug delivery

  2005cites this paper
• Pulmonary Surfactant in Asthma and Allergy

  2005cites this paper
• Nanosuspensions in drug delivery

  2004cites this paper
• A nanoparticle engineering process: spray-freezing into liquid to enhance the dissolution of poorly water soluble drugs

  2003cites this paper
• Nanosizing: a formulation approach for poorly-water-soluble compounds.

  2003cites this paper
• Production and Characterization of a Budesonide Nanosuspension for Pulmonary Administration

  2002cites this paper
• An in-vitro assessment of a NanoCrystal beclomethasone dipropionate colloidal dispersion via ultrasonic nebulization.

  1999cites this paper
• [Liposomes and other nanoparticles as drug delivery systems].

  1999cites this paper
• Process Variable Implications for Residual Solvent Removal and Polymer Morphology in the Formation of Gentamycin-Loaded Poly (L-lactide) Microparticles

  1998cites this paper